Purdue researchers edge closer to delivering personalized medicine to cancer patients

Academic building and snow on the Purdue University campus.

WEST LAFAYETTE, Ind. —

Researchers at Purdue University have developed a technique to better predict chemotherapy resistance in canines and humans.

Chemotherapy can save lives, but often a cancer patient may be resistant to their prescribed chemotherapy, which costs the patient valuable time. Chemoresistance is a topic that researchers need to understand better so that they can match the right type of chemo to the right patient, which is called personalized medicine. 

An unusual pairing of veterinary scientists and physicists at Purdue University believe their method of detecting chemoresistance could be the new standard for personalized medicine. This team is using Doppler ultrasound to detect how cancer cells respond to chemotherapy. They currently have their method of personalized chemotherapy detection in Phase 2 clinical trials in humans at the IU School of Medicine and have also been using the method in canine trials. 

Read more on the Department of Physics and Astronomy website.

Media are encouraged to share, post and publish this content. 

Media contact: Brittany Steff, bsteff@purdue.edu

More Purdue News

A graphic with an “ACTA Gold Standard for Freedom of Expression” banner beside the Purdue Bell Tower in autumn.

Purdue receives Gold Standard designation for fostering a campus culture of free expression

October 29, 2026

Hovde Hall, Purdue University's administrative building, viewed from the front entrance.

Purdue leads on affordability with frozen tuition, accelerated degree pathways

October 29, 2026

The exterior of Birck Nanotechnology Center, which has large windows and a brown facade.

Purdue, GlobalFoundries expand partnership with master research agreement

October 23, 2026

A man talks with three students around a table in the lobby of an academic building.

Purdue’s online cybersecurity degree, AI graduate certificate prepare professionals for emerging digital threats

October 22, 2026